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Abstract
Purpose of review The aim of this review is to provide the
theoretical and practical knowledge essential for non-
radiologists to develop the skills necessary to apply thoracic
ultrasound as an extension of clinical assessment and
intervention.
Recent findings Issues relating to training and competence are
discussed and a library of thoracic ultrasound videos is pro-
vided to illustrate artefacts, pleural, parenchymal and pneumo-
thorax pathology as well as important pitfalls to consider.
Novel and future diagnostic applications of thoracic ultra-
sound in the setting of acute cardiorespiratory pathology in-
cluding consolidation, acute interstitial syndromes and pulmo-
nary embolism are explored.
Summary Thoracic ultrasound requires an understanding of
imaging artefact specific to lung and pleura and a working
knowledge of machine knobology for image optimisation
and interpretation. Ultrasound is a valuable tool for the prac-
ticing chest clinician providing diagnostic information for the
assessment of pleural and parenchymal disease and increased
safety and cost effectiveness of thoracic interventions.
Keywords Thoracic ultrasound . Lung artefact . Pleural
disease . Pleural effusion . Pleural sliding . Seashore sign
Introduction
The uptake of thoracic ultrasound (USS) by chest clinicians
over the last 10 years represents the most important paradigm
shift in procedural pleural medicine since the introduction of
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fine bore intercostal catheters in the 1980s [1, 2]. As well as
guiding thoracentesis, intercostal catheter placement and med-
ical thoracoscopy [3], thoracic USS is valued as an extension
of clinical examination in the evaluation of chest pathologies
involving pleural diseases [4], parenchymal infections [5, 6]
and in the emergent evaluation of the breathless patient [7•, 8].
Whilst thoracic USS has traditionally been the domain of ra-
diologists, non-radiologists have enthusiastically adopted this
readily available tool for the management of pleural and pa-
renchymal lung diseases with outcomes similar to those of
their radiology colleagues [9, 10].
The potential to cause real harm occasioning death [11, 12]
has been the impetus for recent national and international
guidelines [13••, 14–16] recommending in the strongest
terms, if not mandating, that thoracic USS be taught and used
at the bedside prior to attempting invasive thoracic proce-
dures. A growing body of evidence attests to fewer
procedure-related complications in addition to cost savings
associated with USS use [17–21, 22•].
This article provides a sound theoretical and practical guide
for non-radiologist thoracic clinicians to implement point of
care USS techniques in the daily management of pleural and
parenchymal disease. Other reviews on thoracic USS are al-
ready available. However, the real-time nature of USS as a
clinical tool is best demonstrated in video rather than still
image format and the advent of online journals such as
Current Pulmonology Reports, provides capacity to utilise
short video clips to demonstrate normal artefact and thoracic
pathology to further the readers’ understanding.
Ultrasound Hardware and Knobology
Modern USS machines are much smaller and more portable
than in the past making them ideal for use in the emergency
department, respiratory wards and procedure suites. The
newest generation of scanners feature flat, ‘touch’ keyboards
or screens aiming to reduce infection transmission that may
occur on conventional keyboards and control panels.
Two probes are commonly used for lung and pleural USS;
the large convex and the smaller linear probe. Phased array
probes are better suited for cardiac applications and seldom
used in thoracic imaging. Size of the probe face is important to
ensure close contact with the skin surface whilst fitting in the
intercostal space. Generous application of transmission gel is
required to ensure sonic coupling into underlying tissue.
Probe selection depends on the resolution and penetration
required to view the tissue of interest with higher frequency
linear probes providing better resolution but poorer penetra-
tion, due to greater attenuation of sound energy. Most clini-
cians use a linear array probe (with a frequency of around 5–
13 MHz and maximum useful imaging depth of approximate-
ly 6 cm) to view the pleura as it provides excellent resolution
at the short working distances required. These probes are also
extremely useful to guide biopsy of chest wall tumours due to
the available resolution. Convex probes (with frequency
around 1–5 MHz) provide deeper penetration to depths up to
15–18 cm but at the expense of resolution. The curved surface
of the convex probe maymake it difficult to achieve close skin
contact (and therefore sonic coupling) in certain circum-
stances such as thin patients with prominent ribs.
Understanding USS controls is essential to achieve and
maintain a good image. This is often referred to as
‘Knobology’. Although many bedside machines have reduced
the number of controls, it is still important to understand their
function to best optimise and interpret the images seen.
Gain control increases brightness by increasing the ampli-
tude of returning USS waves. Although a bright image may
appear to contain more information, too much gain makes an
image overly bright and obscures fine detail. Time gain
compensation (TGC) controls are intended to compensate
for the attenuation of sound waves that occurs with depth.
TGC is adjusted to make the image brightness more consistent
from superficial to deep with each position on the slide corre-
sponding to a discrete zone of the image. Some machines
simplify this to include only overall, far-field and near-field
gain controls. Dynamic range, often not adjustable on more
mobile machines, controls the compression of the image with
a high dynamic range resulting in lower contrast as the black
and white values are brought closer together and more shades
of grey are displayed in the image. Depth control alters the
scanning depth displayed on the screen, whilst the focal point
of the USS, usually displayed as a triangle or arrow on the side
of the image, indicates where maximum resolution occurs.
Whilst scanning, we recommend the user frequently adjusts
the depth, focus, TGC and overall gain to obtain the best
possible image, a task ideally learnt and initially performed
under direct supervision of an expert sonographer.
The Physiology of Lung Artefacts on Ultrasound
An ultrasound probe positioned on a healthy chest wall accu-
rately images through skin, fascia and muscles but detail ends
abruptly at the convex cortices of the ribs and between them
the pleural line. The high attenuation coefficient of bones [23]
results in absorption of around 60% of the delivered USS
energy with the remaining 40% reflected back towards the
probe. This results in a dark acoustic rib shadow cast distal
to the cortical surface beyond which nothing can be imaged
(video 1). The pleural line, representing effacement of the
parietal and visceral pleura, can be seen between the rib
shadows approximately 1 cm below the rib surfaces (video
1). Respiration and cardiac-induced movement of the visceral
pleura against the fixed parietal pleura results in lung sliding.
The presence of lung sliding excludes a pneumothorax at that
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site (video’s 1 and 5). High acoustic impedance between the
soft tissues above and the air-filled lung below the pleural line
results in reflection of 99.9% of sound energy preventing im-
aging beyond the pleural line unless soft tissue, fluid or con-
solidation replaces healthy lung. Hence, in air-filled lung, the
USS image deep to the pleural line results entirely from arte-
fact rather than real information from returned USS signal. In
the past, these artefacts were thought to make imaging the
lung impossible. However, we now use these to infer normal
and pathological states of the lung. As such, thoracic USS
requires an understanding of the various forms of artefact. In
other organ systems, artefact hinders image interpretation and
complex algorithms are implemented to minimise their effect
such as harmonics, speckle reduction and compound imaging.
Where pleura and lung are concerned, artefacts are fundamen-
tal to interpretation and these algorithms are best left switched
off.
A-lines are a reverberation artefact producing horizontal,
parallel and evenly spaced lines resulting from sound waves
reflected back and forth between the ‘mirror-like’ pleural line
and the USS transducer (Fig. 1, video 1). In the presence of
lung sliding, they indicate a normal visceral and pleural
interface.
B-lines (AKA lung rockets), another form of reverberation
artefact, are fleeting vertical lines that ring down from the
pleural line to the bottom of the US image [24] (video 1).
Their aetiology is complex and incompletely understood.
The presence of one or two B-lines in a single field of view
is normal in healthy individuals, particularly at the lung bases,
but more than two B-lines in such a field or their presence
throughout the lungsmay reflect several pathologies including
thickening of the subpleural interlobular septae through fluid
(acute interstitial oedema), scarring (interstitial pulmonary fi-
brosis) and inflammation (infection/atelectasis/consolidation).
Lung comets are short, often transient vertical reverbera-
tion artefacts thought to arise from small pockets of fluid be-
tween the pleural surfaces (video 1). Unlike B-lines, lung
comets do not extend to the bottom of the US image but
diminish in intensity over a few millimetres. Lung comets
are seen in normal lung and help identify the pleural line.
The Pathology of Pleural Disease
Pleural Effusions
The evaluation of pleural fluid, its presence, volume,
echogenicity and complexity is perhaps the most common
application of thoracic USS. Whilst USS imaging cannot re-
place biochemical and microbiological assessment of pleural
fluid, it does provide clues as to the character of pleural effu-
sion that can be used to assist in determining whether an effu-









Fig. 1 Reverberation artefact
caused by the reflection of the
sound wave back and forth
between the pleural line and
transducer results in equidistant
A-lines
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Four pleural effusion patterns are recognised: anechoic,
complex non-septated, complex septated and echogenic.
Anechoic effusions are black and featureless on USS (video
2). Transudates are almost invariably anechoic; however, an-
echoic effusions may be either transudates or exudates.
Complex effusions contain small specular reflections from
debris within the fluid or areas of increased density. In
complex-septated effusions, the development of fibrin
stranding results in septations within the fluid dividing it into
locules and almost invariably denotes an exudative effusion,
often an empyema (video 2). Echogenic regions within effu-
sions may represent tumours, dense collections of pus (empy-
ema), or even atelectatic lung, mimicking solid lesions. It is
possible for an empyema (or blood) to be so echogenic that it
is not identifiable as an effusion and misinterpreted as lung or
a solid lesion (video 6). Therefore, we recommend that any
unexpected pleural finding should be carefully evaluated from
different angles and in real time to better characterise them.
Pleural Thickening
Pleural thickening can be present on the visceral or pari-
etal pleural surfaces, seen adjacent to the chest wall or
along the diaphragmatic surface when viewed through
an effusion. The contrast of pleural fluid against the pari-
etal pleura makes thickening more easily visible. It usual-
ly appears as hypoechoic thickening and may be caused
by scarring, fibrosis, empyema, pleurisy or tumour. As
pleural thickening is hypoechoic, it can easily be
misinterpreted as a small pleural effusion. A useful way
to help differentiate the two is to evaluate the region with
colour Doppler. Free-flowing fluid will produce a signal
(“Fluid Colour” sign) due to its movement in response to
adjacent lung or cardiac impulse, whereas pleural thick-
ening will be static and produce no Doppler signal [25].
Pleural plaques secondary to asbestos exposure are a rel-
atively common cause of thickening and, if calcified,
show focal reflective areas with dense posterior acoustic
shadowing. Benign asbestos-related pleural plaques are
relatively common; however, other benign pleural masses
are uncommon. Although they are usually well-defined
and of variable echogenicity, these findings should not
be regarded as definitive assessment and other imaging
or a biopsy is usually needed to rule out malignancy.
Malignant pleural masses include mesothelioma, metasta-
sis from lung tumours (frequently adenocarcinoma) or
lymphoma (video 3). Mesothelioma may be nodular or
irregular and is frequently associated with a large effu-
sion. Features strongly suggestive of malignant pleural
effusion, not necessarily from mesothelioma, include pa-
rietal pleural thickening greater than 1 cm, pleural
nodularity and diaphragmatic thickening greater than
0.7 cm [4].
The Pathology of Parenchymal Lung Disease
In addition to the assessment of pleural disease, thoracic USS
can evaluate lung pathology including the identification of
consolidation and lung abscesses and the localisation of tu-
mours for percutaneous sampling.
Consolidation
Lung consolidation can only be identified on USS when
the area of consolidation extends to the pleural surface;
otherwise, as noted earlier, the pleural line forms a barrier
impenetrable to USS energy. When lung becomes consoli-
dated, the normally air-filled alveolar spaces become pro-
gressively fluid filled, able to transduce sound waves and
hence visible on USS. Consolidated lung shows a hetero-
geneous grey appearance on USS (video 4) usually with
irregular or poorly demarcated boundaries. When the con-
solidation abuts a fluid-filled space (pleural effusion) or an
anatomical structure such as the chest wall or diaphragm,
then the edge of the consolidated area is well delineated.
On plain chest X-ray, air-filled bronchi within consolidated
lung are visible as air bronchograms; on thoracic USS,
these interfaces between fluid- and air-filled space result
in artefact represented as dense white short lines, often
projecting distal shadows. These can be followed over time
in three dimensions as branching structures termed dynamic
air bronchograms (video 4). When power or colour
Doppler is used on an area of consolidated lung, the blood
vessels can often be traced throughout the consolidated
lung. The appearances of consolidated lung on USS mimic
those of the liver, and the term hepatisation is used (video
4). As such, it is vital that the liver is separately identified
with a delineating diaphragm separating the two structures.
It is important to recognise that the highly reflective dia-
phragmatic surface may produce a mirror artefact of the
liver seemingly reflected above the diaphragm (video 6).
This should not be mistaken for lung consolidation or a
highly exudative effusion. Provided the abnormalities reach
the pleural surface, thoracic USS is more sensitive than
either traditional bedside examination or conventional
CXR in diagnosing parenchymal consolidation [26].
Tumours and Lung Abscesses
Benign and malignant tumours of the lung can be visualised
by USS providing they abut the pleura. Round or ovoid uni-
formly hypoechoic structures on USS are likely to represent
tumour, though hyperechoic lesions may be seen. A purely
hypoechoic, well-circumscribed mass is most suggestive of a
cyst from pleural, bronchogenic or rarely a parasitic origin. In
areas of tissue necrosis, whether that be due to necrotic tumour
or lung abscess, a fluid density hypoechoic lesion is seen often
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with a hyperechoic wall and USS reflective ‘debris’ vis-
ible within the lesion. Localisation of lung tumours can
be helpful for guiding biopsies, with USS comparable to
CT in terms of sampling accuracy for pleural or periph-
eral lung lesions [27, 28]. In addition, thoracic USS
may be better than CT to assess chest wall invasion
of tumour pre-operatively [29] as well as being able to
apply elastography to determine the elastic properties of
a lung nodule which may in the future be able to dif-
ferentiate malignant from benign lesions [30].
Pneumothorax
Sliding between the visceral and parietal pleura during respi-
ration can be seen on USS in the high reflectivity (white) lines
present at the pleura (video 1). In addition to this, A- and B-
lines (as noted above) are seen to move laterally with respira-
tion. The use of M mode, where the USS return from a single
line of USS energy is displayed through time, highlights this
movement visibly and has been described as a ‘seashore sign’
where the movement of the visceral pleura results in lateral
shift of the lung artefacts (video 5). Tissues above the pleural
line remain relatively static during respiration producing par-
allel lines on M mode—described as ‘waves’, whereas below
the pleural line, artefact appears speckled, like ‘sand’. With a
pneumothorax, the parallel lines are continued below the pleu-
ral line giving rise to the ‘barcode’ appearance on M mode
(video 5). Lastly, power Doppler can be used to view move-
ment of the visceral pleura. The presence of visceral sliding,
the ‘seashore sign’ or power Doppler movement enables
pneumothorax to be ruled out in most circumstances. This
could suggest logically that the absence of these signs ‘rules
in’ pneumothorax. However, this is not the case as other pa-
thology resulting in the absence of pleural movement leads to
the same findings. Such pathology includes pleurodesis
whether therapeutic or spontaneous, hyperinflated lungs with
minimal pleural movement as in COPD, large bullae deep to
the USS probe, obesity, fibrothorax, pulmonary fibrosis and
diaphragm paralysis [31]. In the emergent setting, incorrect
intubation of the right main bronchus leading to left lung col-
lapse may also result in absent pleural sliding. Conversely,
pneumothorax may be incorrectly ‘ruled out’ when bowel
wall or pericardium is mistaken for pleura, or when chest wall
movement due to respiratory effort is interpreted as pleural
sliding (video 6). USS features of pneumothorax are best seen
in the most superior aspect of the chest wall and USS in the
supine patient is more sensitive than CXR to detect pneumo-
thorax. Depending on the size of the pneumothorax, there may
be a site where moving lung remains in direct contact with the
parietal pleura during inspiration, but falls away during expi-
ration. When captured on USS, this is referred to as to the
‘lung point’ sign where the presence and absence of a pneu-
mothorax occur at the same point depending on the phase of
the respiratory cycle (video 5). It must be remembered that
although lung sliding precludes pneumothorax, the absence of
lung sliding does not mean that a pneumothorax is present,
[31]. Also, the presence of lung sliding does not exclude a
significant pneumothorax elsewhere in the same lung. In our
experience, lung sliding on USS does not guarantee that the
lung will drop away completely allowing safe access to the
pleural space, even locally, when a pneumothorax is induced
therapeutically, as is safe to do prior to pleuroscopy [32].
The sensitivity of thoracic USS for the identification of
pneumothorax is less than its specificity (sensitivity in the order
of 90%, specificity 98%); in the circumstances of a rule out test
in a supine trauma patient, it is more sensitive than CXR [33].
The danger comes when the absence of lung sliding, the ‘sea-
shore sign’ or power Doppler are assumed to be pneumothorax,
and intervention wrongly performed on that basis.
A Practical Approach to Bedside Thoracic
Ultrasound
A suggested schema for the approach to bedside thoracic USS
is shown in Table 1. When setting up for USS, it is important
to consider the position of the patient, the operator, the area to
be viewed and how long the procedure is expected to take.
Table 1 An approach to bedside
thoracic ultrasound The five P’s then depth-focus-TGC
Power Turn on the ultrasound unit
Patient Ensure patient demographics are entered to ensure images can be saved
Position Position the patient and ensure a comfortable position for the operator where the screen can be viewed
easily
Probe Select probe—linear, curved linear or phased array




TGC time gain compensation
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There will be obvious differences between the use of
thoracic USS in trauma and a planned thoracic proce-
dure. For thoracic procedures, the patient should be po-
sitioned comfortably with adequate support to maintain
a consistent position for any subsequent drainage or
biopsy procedure. The operator should also consider
their own comfort and ensure proper posture and ergo-
nomics in order to prevent overuse problems, such as
chronic shoulder injuries, a common complaint among
sonographers [34]. The operator should also consider
whether they wish to save images or video to include
in the patient record or maintain a procedural log and
that these controls, as well as image optimisation con-
trols are within easy reach.
The transducer probe should be selected based on the
anticipated depth and character of the target tissue and
any planned procedure. The machine may have a preset
function for lung or pleura, but if not, an abdominal set-
ting may be used for deep penetration of USS into an
effusion. Next, the depth of the target tissue should be
considered. It is usual for the deepest part of the target
to be positioned at about three quarters of the maximum
depth shown on the screen as this allows the image to be
optimised using focus and gain controls. Focus should
then be adjusted to optimise the region of interest, usually
in the middle third of the image. Finally, the TGC controls
should be set to ensure an even gain across the image.
Image optimisation is a dynamic process that should be
continually addressed throughout the scan to maximise
image quality and avoid pitfalls in interpretation (video
6).
It is common to commence scanning on the side opposite
the pathology and for the operator to orientate themselves
using clearly identifiable landmarks such as kidney, liver,
spleen or diaphragm. Especially for the beginner, this helps
orientate the sonographer and when unexpected findings are
encountered, relative tissue densities may be compared with
known organ appearances. It is important to remember that
USS provides a two-dimensional representation of a three-
dimensional object, and USS planes at 90° to each other
should be used to evaluate tissue throughout the scan. It is
common to mark a position on the patient’s skin overlying
the safest area to pass a needle for biopsy or drainage and once
this has been done, the position should be re-checked, again in
two planes, prior to any intervention.
At the completion of a scan, it is important to clean the
probe and machine appropriately, and although alcohol-
containing wipes can be used on the hard surfaces on the
machine and probe, a non-alcohol containing cleaner should
be used on the transducer surface of the probe to avoid
degrading the soft silicon material. There are few risks asso-
ciated with the use of USS but the potential for cross-infection
via probes and USS gel is significant.
Training Requirements
Whilst there is generally an agreement about the importance of
clinician-performed ultrasound for thoracic applications, its use
‘remains highly operator-dependent in spite of advances in tech-
nology, and the interests of the patient are best served by the
provision of an USS service which offers the maximum clinical
benefit and optimal use of resources, i.e. with appropriately
trained personnel using equipment of appropriate quality’ [35].
Training in thoracic USS is available at various levels in
Europe, North America and the Asia Pacific. A typical 1- to 2-
day workshop offers lectures in basic US physics, thoracic
anatomy, pleural and parenchymal pathology, supervised
hands on practice using simple and/or high fidelity phantoms
as well as practice on patients with a variety of pleural pathol-
ogies. Some courses also cover different approaches to USS-
guided needle aspiration and drain insertion. These are gener-
ally viewed as introductory courses and designed to be follow-
ed by supervised implementation and skill acquisition at the
point of care, with assessment during or after completion of a
logbook of cases performed. However, attending a course and
keeping a logbook does not equate to competence, and mea-
sures of competence assessment are required to confirm ade-
quacy of crucial skills such as insertion site for accessing the
pleural space. Recently, thoracic USS assessment tools have
been developed to assist in the determination of competence.
The UG-STAT is an 11-point assessment task that tests basic
USS acquisition skills, image interpretation and localisation of
safe ICC insertion sites on either phantoms or real patients and
can reliably differentiate novice, intermediate and expert users
[36••]. Vetrugno et al. developed an assessment task combin-
ing pleural USS with ICC insertion technique in phantoms
showing significant differences between novice and expert
groups in the critical care setting [37].
Many professional societies and institutions provide ac-
creditation pathways and programs for clinicians in the use
of thoracic USS. In the UK, the Royal College of
Radiologists in conjunction with the physicians training board
mandate a user-directed pathway involving attendance at an
accredited course, supervised scanning sessions (minimum 35
scans), a procedure logbook and a competence sheet complet-
ed. A novel structured program recently implemented in
Australia and New Zealand requires attendance at an
accredited course followed by close point of care supervision
of USS procedures and documentation of each scan in a log-
book (minimum 40 scans) together with a UG-STAT assess-
ment after 10, 20 and 40 scans, the final assessment being a
barrier exam (pass mark 90%) [38].
Moving forward, it is suggested that local professional bod-
ies develop accreditation pathways suited to their regional
requirements to ensure that as the uptake of thoracic USS
broadens, individuals are provided with the necessary skills
and training to ensure competence is achieved.
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Future Directions
The benefits of USS have been well described in the manage-
ment of pleural effusion, particularly in reducing the rate of
iatrogenic pneumothorax from thoracocentesis. Studies have
shown that the rate of pneumothorax can be reduced by up to
19% through the use of USS [22•]. Bleeding complications
from thoracocentesis are less common [39]. Abnormal
haemostasis has traditionally been considered a risk factor,
but recent studies where USS has been used to delineate vis-
ceral structures at risk of perforation suggest that this risk may
be overstated [39, 40]. Salamonsen et al. have suggested that
USS may also be used to identify exposed intercostal arteries
vulnerable to injury in order to further reduce risk [41].
Though promising, the accuracy of USS and the impact on
rate of complications requires further research.
Other pleural procedures may benefit from USS use. Real-
time USS is comparable to CT in sampling accuracy of pleural
lesions, with decreased complications and cost [27]. Physician
(as opposed to radiologist) performed closed pleural biopsy un-
der real-time ultrasound guidance has high rates of successful
diagnostic sampling [42] and has been advocated as a first line
investigation after non-diagnostic aspiration of exudative pleural
effusions, potentially replacing thoracoscopy [43].
The role of USS is less well defined in consolidation or
interstitial syndromes. A recent review of the literature sug-
gests that USS is more sensitive than CXR for detection of
consolidation [44]. However, differentiating between poten-
tial aetiologies (such as pneumonia and pulmonary embolism)
is heavily dependent on clinical evaluation and suspicion. In
the case of pulmonary embolism, two meta-analyses showed
sensitivities for diagnosis of PE by thoracic ultrasound of 85%
or more [45, 46]. However, the high prevalence of pulmonary
embolism in these studies suggests that the USS may only be
of use in patients with a high pre-test probability of PE where
CTPA is unavailable or contraindicated.
Similarly, in the case of interstitial syndrome, B-lines may
be seen with a variety of pathologies. In pulmonary oedema,
the number of B-lines on USS has been shown to correlate
with extravascular lung water [47], and a recent review dem-
onstrated that thoracic ultrasound had the highest positive
likelihood ratio for heart failure when compared to clinical
examination, ECG and CXR [48]. B-lines may also be seen
with pulmonary fibrosis, and their presence has been used to
screen for lung involvement in connective tissue diseases [49].
Other pathologies that may cause B-lines include pneumonia,
pulmonary contusions and acute respiratory distress syn-
drome. Whilst various USS findings have been described to
aid in discriminating between these conditions [50–52], their
accuracy remains problematic.
In both parenchymal and interstitial lung diseases, the ex-
panded use of USS may improve diagnostic accuracy. For ex-
ample, thoracicUSS combinedwith lower limb venousUSS and
echocardiographic assessment increased sensitivity for diagnosis
of PE [53]. However, the precise role of USS as a screening tool
or as a replacement test remains to be firmly established. At
present, it is suggested that physician-performed USS be used
to answer simple clinical questions as part of a Bayesian diag-
nostic approach to avoid the risks of incorrect interpretation.
Finally, whilst USS has been available for decades, ongo-
ing technological developments raise the possibility of new
applications. The recent advent of handheld machines and
smartphone probe attachments potentially allow for USS as-
sessment as part of routine clinical examination. Colli et al.
demonstrated that the use of pocket USS in combination with
clinical examination obviated the need for further testing in
95% of patients for whom there was a clinical question of
pleural effusion [54]. Another pilot study demonstrated that
use of pocket USS by a medical student could screen for the
presence of left ventricular systolic dysfunction with a similar
sensitivity and specificity to an experienced echocardiologist
[55]. Computer algorithms have also been developed to ana-
lyze USS images for B-lines [56] and pneumothoraces [57].
Whilst further research and development is required, their use
may aid accuracy and reproducibility of USS interpretation,
particularly for less experienced clinicians.
Conclusions
Thoracic interventions should no longer be performed without
contemporary imaging and ultrasound represents an accurate,
available and cost-effective tool to enable such interventions
at the bedside by appropriately trained clinicians. A compre-
hensive understanding of the sound properties of tissue, air
and fluid and the way these interact to produce artefacts is
essential for image interpretation as is sufficient bedside ex-
perience to apply point of care USS to extend the clinical
assessment of pleural and parenchymal disease. Training for
current and future chest clinicians should be widely accessible
and incorporated into respiratory, cardiothoracic and emergen-
cy medicine training curricula and assessment of competence
encouraged. It is important to remember that clinicians trained
in thoracic USS, particularly in the early part of their careers,
are unlikely to have acquired the same level of skill as radiol-
ogists or more experienced USS-trained colleagues and we
would encourage a close collaborative relationship with such
individuals to maximise learning and skill acquisition with the
ultimate aim of providing optimal patient care.
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